About the Moderator
Jennifer Schünemann is a publisher, mentor, and proven, successful entrepreneur in the world of international medical publishing. At 32 she started her first company, and in 2014 sold The Goodwin Group International to the world’s 5th largest journals publisher, SAGE Publications Inc. At the time of sale, Ms. Schünemann’s hallmark publication, MD Conference Express, reached more than 1 million medical practitioners in more than 95 countries, in 16 languages. Upon joining SAGE, Ms. Schünemann was appointed to the Senior Management Group, tasked with leading the 1500+ employee organization with principal offices in Boston, Los Angeles, London, New Delhi, Singapore, and Washington, D.C. In 2016 she founded the New England chapter of Durga Tree International, a global charity that fights human trafficking, and in 2017, she was appointed to the Board of Directors of the Umbrella Community Arts Center.
Ms. Schünemann speaks four languages, and has traveled to 52 countries. She holds a dual Bachelor’s of Arts Degree from the University of Pennsylvania, and has studied and lived abroad in Paris, France where she took courses at the Paris Institute of Political Studies (Sciences Po). She is a Chairman Circle member of the French Heritage Society, and a member of the American Friends of Lafayette.
Le Business, a Series
In honor of his legacy, the French Cultural Center / Alliance Française of Boston and Cambridge and The French American Chamber of Commerce of New England proudly present a special series dedicated to French and American perspectives on business—from startups, healthcare, and biotech, to cross-cultural challenges in a global economy.
Co-presented with the French American Chamber of Commerce of New England, this panel will explore the validity of President Macron’s desire to embrace entrepreneurship, and compare the evolving business landscapes of Paris and Boston.Read More
For the second event in our special business series, we will compare the French and American healthcare systems and how they define research and investments in the biomedical field.Read More